Neogenix Oncology Files Patent Application For 16C3 Antigen
Based on in vitro and animal studies, Neogenix believes that the 16C3 antibody has anti-tumor activity for both pancreatic and colorectal tumors, and may have both therapeutic and
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).